Predictors of treatment outcomes following anti-vascular endothelial growth factor (VEGF) therapy for Neovascular AMD.

老年性黄斑变性(AMD)是发达国家老年人群中最常见的严重、不可逆转的视力丧失的原因。视网膜出血会破坏中心视力。已经开发出新的治疗方法来止血。然而，并不是所有的患者都能平等受益，一些患者仍然失去了视力。这个项目的目的是调查是什么决定了一个人对治疗的反应如何，特别是基因可能如何影响反应。

Age-related macular degeneration (AMD) is the most common cause of severe, irreversible loss of vision amongst elderly populations in the developed world. Bleeding in the retina destroys central vision. New treatments have been developed to stop this bleeding. However not all patients benefit equally, with some still losing vision. This project aims to investigate what determines how well an individual responds to treatment, in particular, how genes might influence the response.